Skip to main content
Home
Browse by Topic
Issues
Latest Issue
Issue Archive
Special Issues
Web Exclusives
Special Series
Conference Correspondent
ASH 2023 - CLL
Ovarian Cancer Overview
Multimedia
All Videos
Interview with the Innovators
Quick Quiz
Subscribe
Home
Browse by Topic
Issues
Latest Issue
Issue Archive
Special Issues
Web Exclusives
Special Series
Conference Correspondent
ASH 2023 - CLL
Ovarian Cancer Overview
Multimedia
All Videos
Interview with the Innovators
Quick Quiz
Subscribe
Steven Selde
Director
Biosimilars Council, a Division of the Association for Accessible Medicines Pharmaceutical Manufacturing
Washington, DC
Authored Items
HHS OIG Report Demonstrates Need for Changes to Part D to Increase Biosimilar Use
By
Steven Selde
TOP - May 2022 Vol 15, No 3
Biosimilars
Biosimilars provide more options for care at a lower cost for patients, but due to Medicare’s perverse incentives, many pharmacy benefit managers and health plans have been slow to prioritize biosimilars, leaving savings on the table.
Read More ›